SHH Equity Snapshot

688235 Weekly Equity Report

BeOne Medicines AG

Interactive chart JSON snapshot
Latest Close 216.4 CNY 12 Jun 2026
1W Return -1.7% latest completed week
4W Return -14.1% short-term follow-through
12W Return -4.9% quarterly tape
Trend Breadth 67.3% 35 of 52 weeks active
Volume Ratio 0.9x vs 13-week average
Company Brief

What the company does

BeOne Medicines AG, an oncology company, engages in discovering and developing various treatments for cancer patients in the United States, China, Europe, and internationally. The company's commercial stage products include BRUKINSA, a small molecule inhibitor of Bruton's Tyrosine Kinase (BTK) for the treatment of various blood cancers; TEVIMBRA, an anti-PD-1 antibody immunotherapy for the treatment of various solid tumor and blood cancers; SYLVANT for the treatment of adult patients with multicentric castleman disease; BAITUOWEI for patients with BC in premenopausal and perimenopausal women, and cancer; and PARTRUVIX for the treatment of various solid tumors. Its …

Snapshot

What the weekly tape is saying

688235 closed the latest completed week at 216.4 CNY. The 4-week return is -14.1% and the 12-week return is -4.9%. Trend Signal is inactive, Market Dynamics is -0.04. Setup signature: Risk-first tape with a 25/100 composite read.

Trend Signal Inactive
Market Dynamics No fresh buy
Price vs Trend -16.7%
Volume 0.9x
Setup Cockpit

A compressed read of the whole setup

The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.

Composite setup radar

Scoreboard

Trend 37 Persistence of active Trend Signal over the last year and current streak.
Momentum 13 Blend of 4-week and 12-week follow-through.
Dynamics 57 Latest Market Dynamics and whether pressure has improved over four weeks.
Relative Strength 0 Relative leadership and short-term RS change.
Volume 39 Participation compared with the 13-week volume baseline.
Risk Control 3 Drawdown and recent weekly volatility pressure.

16-week signal tape

27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun
Weekly return bar Trend Signal dot Positive Market Dynamics dot
Price Action

Price, Trend Line, and Fair Value

Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.

52-week price path

Price Trend Line Fair Value

Price map

Trend Line
259.6 CNY
Vs Trend Line
-16.7%
Fair Value
191.6 CNY
Vs Fair Value
13.0%
52W High
346.0 CNY
52W Low
205.5 CNY
Drawdown
-37.5%
Range Position
7.7%
Momentum

Returns and trend persistence

Return windows separate the latest week from short-term and medium-term follow-through.

Return windows

1W -1.7%
4W -14.1%
12W -4.9%
26W -22.5%
52W -8.2%

Trend read

Active Streak
0 weeks
52W Active Weeks
35
52W Active Breadth
67.3%
Sector Scope
CN Healthcare
Sector Rank
215 of 486
Sector Percentile
55.9%
Peer Context

Sector and industry pulse

Peer breadth helps separate a stock-specific move from a broader group rotation.

Market Dynamics

Pressure, Relative Strength, and expectation

Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.

Dynamics path

Market Dynamics Relative Strength

Signal state

Market Dynamics
-0.04
4W MD Change
93.9%
Relative Strength
-20.62
4W RS Change
-86.2%
Expectation
Undecided
Probability
47.58%
Volume

Participation and confirmation

Volume tells us whether the latest weekly move is being confirmed by unusual participation.

52-week volume profile

Volume map

Latest Volume
16.6M
13W Average
18.2M
52W Average
16.8M
Vs 13W
0.9x
Vs 52W
1.0x
Risk Anatomy

Volatility, downside weeks, and return shape

A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.

26-week return distribution

Risk map

13W Volatility
3.7%
52W Volatility
5.6%
Upside Weeks
22
Downside Weeks
30
Downside Breadth
57.7%
Avg Gain / Loss
5.1% / -3.8%
Context

Classification, opportunities, risks, and watch points

Top-level read across company classification, constructive evidence, caution points, and the next things that matter.

Classification

Exchange
SHH
Country
CN
Sector
Healthcare
Industry
Biotechnology
Currency
CNY
Market Cap
297.8B

Opportunity signals

  • Price is above Fair Value, showing premium demand versus the model.

Risk signals

  • Trend Signal is inactive, so price action has not confirmed a constructive regime.
  • Price is below the Trend Line, which keeps downside pressure in focus.
  • Market Dynamics is negative, which weakens the current setup.
  • The share remains more than 20% below its 52-week high.

Watch next

  • Trend Line remains the key weekly regime level.
  • Market Dynamics is the pressure gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Weekly Tape

Recent completed weeks

The latest weekly rows behind the report snapshot.

Week Close Return Trend Fair Value MD RS Volume Signal
12 Jun 2026 216.4 CNY -1.7% 259.6 CNY 191.6 CNY -0.04 -20.62 16.6M Off
5 Jun 2026 220.2 CNY -9.7% 261.7 CNY 191.1 CNY 0.13 -19.51 20.3M Off
29 May 2026 243.9 CNY -0.3% 264.3 CNY 190.6 CNY 0.05 -12.08 21.0M Off
22 May 2026 244.6 CNY -3.0% 265.5 CNY 190.0 CNY -0.30 -13.01 22.9M Off
15 May 2026 252.0 CNY 1.8% 266.4 CNY 189.4 CNY -0.66 -11.08 26.6M Off
8 May 2026 247.5 CNY 5.4% 267.6 CNY 188.8 CNY -0.84 -13.89 15.3M Off
1 May 2026 234.8 CNY -0.0% 269.5 CNY 188.3 CNY -0.92 -17.43 9.7M Off
24 Apr 2026 234.9 CNY -4.7% 271.8 CNY 187.8 CNY -0.74 -17.12 13.3M Off
17 Apr 2026 246.5 CNY 1.0% 274.3 CNY 187.3 CNY -0.62 -12.76 20.5M Off
10 Apr 2026 244.1 CNY 2.0% 276.6 CNY 186.6 CNY -0.76 -12.47 11.7M Off
3 Apr 2026 239.3 CNY 2.8% 279.1 CNY 185.9 CNY -0.77 -12.19 23.4M Off
27 Mar 2026 232.7 CNY 2.2% 280.4 CNY 185.2 CNY -0.81 -15.52 20.6M Off
20 Mar 2026 227.6 CNY -0.5% 280.9 CNY 184.6 CNY -0.89 -18.44 14.0M Off
13 Mar 2026 228.7 CNY -4.1% 281.3 CNY 184.0 CNY -0.82 -20.93 14.9M Off